Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.

@article{Chang2011GastrooesophagealRT,
  title={Gastro-oesophageal reflux treatment for prolonged non-specific cough in children and adults.},
  author={Anne B. Chang and Toby J Lasserson and Justin Gaffney and Frances L Connor and Luke Albert Garske},
  journal={The Cochrane database of systematic reviews},
  year={2011},
  volume={1},
  pages={
          CD004823
        }
}
BACKGROUND Gastroesophageal reflux disease (GORD) is said to be the causative factor in up to 41% of adults with chronic cough. Treatment for GORD includes conservative measures (diet manipulation), pharmaceutical therapy (motility or prokinetic agents, H(2)-antagonist and proton pump inhibitors (PPI)) and fundoplication. OBJECTIVES To evaluate the efficacy of GORD treatment on chronic cough in children and adults with GORD and prolonged cough that is not related to an underlying respiratory… 

Figures from this paper

Respiratory manifestations of gastro-oesophageal reflux in children
TLDR
Evidence for the assessment of children with suspected extraoesophageal manifestations of GORD is scanty and longitudinal studies with long-term follow-up are urgently required.
Response of chronic cough to acid-suppressive therapy in patients with gastroesophageal reflux disease.
TLDR
Evidence suggests that rigorous patient selection is necessary to identify patient populations likely to be responsive to antireflux therapy, using physiologically timed cough events during reflux testing, minimal patient exclusion because of presumptive alternative diagnoses, and appropriate power to detect a modest therapeutic gain.
Gastro-oesophageal reflux disease and non-asthma lung disease
TLDR
Proton-pump inhibitors are the medications of choice for GERD; other interventions shown to reduce reflux are weight loss, elevation of the head of the bed and avoidance of recumbency after meals, but acid suppression therapy does not address non-acid reflux that may be important in disease pathogenesis in select patients, and lifestyle modifications often fail.
Republished: Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?
TLDR
From the clinical data available, the best treatment results and, hence, the patients most likely to benefit from reflux inhibitors, are those with persistent reflux, most commonly manifest as persistent regurgitation despite PPI treatment.
Failure of reflux inhibitors in clinical trials: bad drugs or wrong patients?
TLDR
From the clinical data available, the best treatment results and, hence, the patients most likely to benefit from reflux inhibitors, are those with persistent reflux, most commonly manifest as persistent regurgitation despite PPI treatment.
Gastroesophageal Reflux in Chronic Cough and Cough Syncope and the Effect of Antireflux Treatment
TLDR
In treating well-selected GER-related chronic cough and cough syncope, PPI, SRF, and LF can be considered and satisfactory restoration of physical and social functions could be achieved after effective antireflux therapy.
Should Acid Suppressive Therapy Improve Chronic Cough? (Chest 2013;143:605-612)
  • J. Oh
  • Medicine
    Journal of neurogastroenterology and motility
  • 2013
TLDR
A therapeutic benefit for acid suppressive therapy in patients with chronic cough cannot be dismissed, and it would be much more effective in selective patients who are favorable to therapy based on symptoms or reflux testing.
...
...

References

SHOWING 1-10 OF 106 REFERENCES
Gastro-oesophageal reflux related cough and its response to laparoscopic fundoplication
TLDR
Laroscopic Nissen fundoplication is effective in the control of cough in patients with gastro-oesophageal reflux disease, with or without primary respiratory disease.
Chronic cough due to gastroesophageal reflux disease
TLDR
Twenty-four-hour esophageal pH monitoring is a valuable tool for preoperative cough—reflux correlation and antireflux surgery is effective in carefully selected patients whose refractory CC is attributable only to GERD.
Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
TLDR
Four to 6 weeks of a proton-pump inhibitor alone or in combination with a prokinetic agent successfully diagnoses and treats four of five patients with GERD-related cough.
Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole.
TLDR
Omprazole 40 mg o.d seems to improve chronic cough in patients with gastrooesophageal reflux and the effect of omeprazole in ameliorating both cough and reflux symptoms continues after treatment ceases.
Therapy Insight: treatment of gastroesophageal reflux in adults with chronic cough
TLDR
Clinical practice guidelines from the American College of Chest Physicians and the British Thoracic Society recommend initiating an initial empiric GER therapy trial, with esophageal testing being reserved for nonresponders.
Effects of anti-reflux surgery on chronic cough and asthma in patients with gastro-oesophageal reflux disease.
TLDR
In conclusion, anti-reflux surgery in patients with GORD had a more favourable effect on concomitant cough thanConcomitant asthma.
Diagnosis and treatment of chronic cough due to gastro-esophageal reflux disease and postnasal drip syndrome.
TLDR
Because there are no pathognomonic findings of PNDS, the diagnosis is inferential and is based upon a combination of clinical findings, the results of ancillary testing, and the response to specific therapy.
Effect of Antisecretory Therapy on Atypical Symptoms in Gastroesophageal Reflux Disease
TLDR
It is concluded that atypical symptoms are frequent in patients with GERD and a trial of PPI therapy should be considered prior to referring these patients to specialists.
Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.
TLDR
Twelve weeks of lansoprazole treatment even at a standard daily dose, is effective in patients with chronic persistent cough and a positive response to an initial PPI test seems to be the best criterion for selecting patients who respond to therapy.
...
...